Saintno Pharmaceutical-B has completed the issuance of 17.5277 million shares.

Shengnuo Pharmaceutical-B (02257) announced that on December 2, 2024, it will issue 17.5277 million shares after completing the subscription of new shares according to the general authorization based on the subscription agreement dated October 2, 2024.

Sina Hong Kong StocksDec 2 19:52 ET

Express News | Sirnaomics Ltd - Got Letter of Resignation From Shing Mo Han, Yvonne to Resign as Chairperson of Board

ReutersNov 27 06:00 ET

Express News | Sirnaomics Ltd - Yang Lu Re-Designated From an Executive Director to a Non-Executive Director

ReutersNov 5 17:11 ET

San Nova Pharmaceutical-B (02257.HK): Lu Yang and Sheng Muxian resign as members of the investigation committee.

GraceAlliance October 29th, Shengnuo Pharmaceuticals-B (02257.HK) announced that the board of directors has established an investigation committee, chaired by the chairman of the board and executive director Lu Yang, along with all independent non-executive directors, namely Chang Hai, Huang Mengying, and Shengmuxian, to investigate the incident that the issuer of the private placement bonds invested by the fund may default, expecting a significant adverse change in the net asset value of the fund. The board of directors has received notifications from Lu Yang and Shengmuxian voluntarily resigning as members of the investigation committee to devote more time to their respective duties prior to being appointed as members of the investigation committee, effective October 29, 2024.

Gelonghui FinanceOct 29 10:25 ET

San Nuo Medicine-B (02257): Pan Honghui appointed as an executive director.

San Nova Pharmaceuticals-B (02257) announced that Dr. Pan Honghui has been appointed as an executive director, effective from October 2024...

Zhitong FinanceOct 15 08:36 ET

Express News | Sirnaomics Ltd - Poon Hung Fai Appointed as Executive Director

ReutersOct 15 08:35 ET